A Simple Way to Manage Diabetes 

Say Hello to Bigfoot UnityTM

 

LEARN MORE

SystemwithFreeStyleLogo

 

The First FDA Cleared Dose Decision Support System Integrated with iCGM1

It’s not a myth. Bigfoot is real. Introducing the Bigfoot Unity™ Diabetes Management System, the first-of-its-kind smart pen caps that incorporate integrated continuous glucose monitor (iCGM) data and health care provider instructions to provide insulin dose recommendations for people with diabetes who use multiple daily injections (MDI) of insulin.1

The System, which is the centerpiece of our larger Bigfoot Unity™ Diabetes Management Program, takes a holistic approach to simplify and connect key aspects of insulin management. At its heart is the FreeStyle Libre 2 sensor that provides the Bigfoot Unity System with hypoglycemia2 alerts in real time.3 The FreeStyle Libre brand is the #1 CGM worldwide.4

The Bigfoot Unity System is designed to clearly, and in real time, help answer the question, “How much insulin would my doctor recommend I take right now?”

 

BIGFOOT UNITY

 

 

Your Real-Time Partner in Diabetes Management

Introducing the Bigfoot Unity™ Diabetes Management Program, a real-time partner to health care providers (HCP) to help support their patients using MDI insulin regimens. Now endocrinology practices and diabetes centers in the United States have a solution available that:

  • Enables individual patient success with an innovative, FDA cleared system

  • Equips your clinic with tools to scale Population Health Management

  • Automatically collects data to support Remote Physiologic Monitoring (RPM) by HCPs

LEARN MORE

 

“

What the world of diabetes needs is a greater focus on simplicity, ease of use, and broadening access. It is through a focus on maximizing these qualities that the daily burden of diabetes can be relieved to the greatest extent for the largest population.

- Jeffrey Brewer, CEO

Our Vision for Diabetes Management

 

By providing simple and easy-to-use solutions, Bigfoot Biomedical aims to reduce the burden on people with insulin-requiring diabetes, improve access and health equity, and support health care providers in optimizing diabetes care.

 

VIEW VIDEO

Join our team and make a difference in the world.

We have recruited the right expertise from medtech, enterprise software, and consumer technology to assemble a dream team of talented professionals dedicated to tackling a tough disease. Deep in our lair in the heart of Silicon Valley, each member brings his or her own skill set, spirit, and commitment to what we’re promising, declaring #IBelieveInBigfoot!

 

CAREERS

Bigfoot Team Member Stories

Beth Salmon, Sr Director Product and User Experience

"I believe in Bigfoot because we're going to make it much less scary... for me, for my kids, and for moms everywhere."

 

TEAM STORY

Have Questions? We’re Here to Provide Answers.

 

Our Contact page provides quick access for health care providers, media and general inquiries.

 

CONTACT US

1 Based on available products for multiple daily injection therapy of insulin as of May 2021.
2 Table 6.4 - Classification of hypoglycemia. American Diabetes Association. Glycemic targets:Standards of Medical Care in Diabetes–2021. Diabetes Care 2021;44(Suppl. 1):S73–S84. https://doi.org/10.2337/dc21-S006
3 In order to receive alerts, notifications and Critical Alerts must be turned on and the sensor must be within 20 feet of the phone with the Bigfoot Unity Mobile App active. Alerts only available on the phone. For compatible phones, please visit www.bigfootbiomedical.com/compatible.
4 Data based on the number of users worldwide for FreeStyle Libre family of personal CGMs compared to the number of users for other leading personal CGM brands and based on CGM sales dollars compared to other leading personal CGM brands.


The circular shape of the sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott and used with permission.

WEB-400003 Rev C, 04/21